Literature DB >> 7479555

Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans.

B H Stewart1, O H Chan, R H Lu, E L Reyner, H L Schmid, H W Hamilton, B A Steinbaugh, M D Taylor.   

Abstract

In vitro and in situ experimental models that are descriptive of drug absorption in vivo are valuable tools in the discovery of new chemical entities that are bioavailable after oral administration. The specific objective of the study was to compare the intestinal permeabilities obtained in the three absorption models for consistency, and to assess the utility of the models in predicting the fraction of dose absorbed in human studies. The intestinal absorption models that were compared are widely used: the rat in situ single-pass intestinal perfusion system, the rat everted intestinal ring method, and monolayers of human colon adenocarcinoma cell line (CACO-2). The models were compared using small molecular reference compounds, as well as a series of peptidomimetic (PM) analogs. Each model had strong potential for estimating the fraction absorbed. For small organic molecules, excellent correlation was observed when permeabilities from CACO-2 cells and perfusions, or everted rings and perfusions, were compared. Weaker correlation was observed between everted rings and CACO-2 cells. Permeabilities for the set of reference compounds and PMs were positively correlated between any two of the three systems. Variance between correlations for reference compounds and PMs are likely due to structural features and physicochemical properties that are unique to the latter class of compounds. The results support caution in extrapolating correlations based on findings with small organic molecules to the behavior of complex peptidomimetics. Corroboration of permeabilities with two methods of determination is a useful cross-validation of experimental systems, as well as producing a reliable permeability assessment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7479555     DOI: 10.1023/a:1016207525186

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

Review 1.  Intestinal absorption of peptides.

Authors:  D M Matthews
Journal:  Physiol Rev       Date:  1975-10       Impact factor: 37.312

2.  In vitro studies of intestinal drug absorption. Determination of partition and distribution coefficients with brush border membrane vesicles.

Authors:  C J Alcorn; R J Simpson; D Leahy; T J Peters
Journal:  Biochem Pharmacol       Date:  1991-11-27       Impact factor: 5.858

3.  In vitro drug absorption models. I. Brush border membrane vesicles, isolated mucosal cells and everted intestinal rings: characterization and salicylate accumulation.

Authors:  I Osiecka; P A Porter; R T Borchardt; J A Fix; C R Gardner
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

4.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

5.  Evaluation of physicochemical parameters important to the oral bioavailability of peptide-like compounds: implications for the synthesis of renin inhibitors.

Authors:  H W Hamilton; B A Steinbaugh; B H Stewart; O H Chan; H L Schmid; R Schroeder; M J Ryan; J Keiser; M D Taylor; C J Blankley
Journal:  J Med Chem       Date:  1995-04-28       Impact factor: 7.446

6.  Uptake of prodrugs by rat intestinal mucosal cells: mechanism and pharmaceutical implications.

Authors:  B H Stewart; G L Amidon; R K Brabec
Journal:  J Pharm Sci       Date:  1986-10       Impact factor: 3.534

7.  A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa.

Authors:  D C Kim; P S Burton; R T Borchardt
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

8.  Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds.

Authors:  G L Amidon; P J Sinko; D Fleisher
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

9.  A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

Authors:  B H Stewart; A R Kugler; P R Thompson; H N Bockbrader
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  In Vitro Drug Absorption Models. II. Salicylate, Cefoxitin, α-Methyldopa and Theophylline Uptake in Cells and Rings: Correlation with In Vivo Bioavailability.

Authors:  P A Porter; I Osiecka; R T Borchardt; J A Fix; L Frost; C Gardner
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

View more
  38 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities.

Authors:  L C Kaus; W R Gillespie; A S Hussain; G L Amidon
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Transport of pregabalin in rat intestine and Caco-2 monolayers.

Authors:  N Jezyk; C Li; B H Stewart; X Wu; H N Bockbrader; D Fleisher
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

4.  Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note.

Authors:  Chayapathy Issa; Piyush Gupta; Arvind K Bansal
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

Review 5.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

6.  Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.

Authors:  Maris A Cinelli; Huiying Li; Anthony V Pensa; Soosung Kang; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2015-10-27       Impact factor: 7.446

Review 7.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

8.  A novel method for the investigation of liquid/liquid distribution coefficients and interface permeabilities applied to the water-octanol-drug system.

Authors:  Paul C Stein; Massimiliano di Cagno; Annette Bauer-Brandl
Journal:  Pharm Res       Date:  2011-04-14       Impact factor: 4.200

Review 9.  Towards quantitative prediction of oral drug absorption.

Authors:  Jennifer B Dressman; Kirstin Thelen; Ekarat Jantratid
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Computational approaches for modeling human intestinal absorption and permeability.

Authors:  Govindan Subramanian; Douglas B Kitchen
Journal:  J Mol Model       Date:  2006-04-01       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.